Loading...

Rare Disease And Neuroinflammation Platforms Will Unlock Significant Long-Term Upside Potential

Published
06 Dec 25
Views
8
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-62.0%
7D
-12.9%

Author's Valuation

US$876.4% undervalued intrinsic discount

AnalystHighTarget Fair Value